Key facts
- This page summarizes STELLARS CAPITAL PRIVATE I Ltd's Form 3 filing for Harvard Apparatus Regenerative Technology, Inc. (HRGN).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 26 Sep 2024, 09:27.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
Additional SEC filing notes
Footnote F1
The reported securities are directly owned by StellarS Capital Private I Limited, a Cayman Islands corporation. Mao Zhang is the director of StellarS Capital Private I Limited and disclaim beneficial ownership of the reported securities except to the extent of his respective pecuniary interest therein, if any, and this report shall not be deemed an admission that either of them are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.